Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Hepatobiliary Pancreat Dis Int. 2023 May 9;22(5):474–481. doi: 10.1016/j.hbpd.2023.05.003

Table 4.

Simple linear regression of fecal cytolysin with liver disease markers for combined cohort

Outcome Variable Estimate 2.5 % 97.5 % p value
FIB-4 Cytolysin −1.68 −9.82 6.46 0.68
ABIC Cytolysin 0.03 −0.81 0.88 0.93
Child-Pugh Cytolysin 0.58 −0.52 1.68 0.30
MELD Cytolysin 0.11 −2.95 3.16 0.95
MELD-Na Cytolysin −0.02 −3.63 3.59 0.99

Cytolysin n=78, FIB-4 n=74, ABIC n=77, Child-Pugh=74, MELD score n=77, and MELD-Na score n=77. ABIC, ‘Age, serum bilirubin, INR, and serum creatinine score’; FIB-4, Fibrosis-4 Index; INR, international normalized ratio; MELD, model for end-stage liver disease; MELD-Na, sodium-adjusted model for end-stage liver disease.